The Competition Commission of India (CCI) has approved the proposal of Tau Investment to acquire shares in J B Chemicals & Pharmaceuticals.Â
The proposed combination envisages acquisition of up to 64.90% of share capital of J B Chemicals & Pharmaceuticals by Tau Investment.
Tau Investment is a company incorporated in Singapore. It is an indirect, wholly-owned subsidiary of KKR Asian Fund III. It is an affiliate of funds, vehicles and/or entities managed and/or advised by Kohlberg Kravis Roberts & Company which is an indirect subsidiary of KKR & Company.
J B Chemicals & Pharmaceuticals is an Indian pharmaceutical company, headquartered in Mumbai, Maharashtra.